Original Article Increased Expression of Sestrin2 in Human and Experimental Heart Failure
Total Page:16
File Type:pdf, Size:1020Kb
Int J Clin Exp Pathol 2016;9(8):8075-8082 www.ijcep.com /ISSN:1936-2625/IJCEP0026068 Original Article Increased expression of Sestrin2 in human and experimental heart failure Menglong Wang*, Jianfang Liu*, Juanjuan Qin, Menglin Liu, Ying Feng, Lei Shi, Wenhui Yuan, Jing Ye, Jun Wan Department of Cardiology, Cardiovascular Research Institute, Hubei Key Laboratory of Cardiology, Renmin Hospi- tal of Wuhan University, Wuhan, PR China. *Equal contributors. Received February 16, 2016; Accepted June 13, 2016; Epub August 1, 2016; Published August 15, 2016 Abstract: Background: Sestrins (Sesns) are originally identified as critical antioxidant proteins and involved in com- plex regulation of cell viability in response to diverse stress conditions. However, the exact expression and func- tion of Sesns in heart failure (HF) remains unclear. Methods and results: Sesns expression was detected in heart samples from end-stage HF patients and unmatched donors by real-time polymerase chain reaction (RT-PCR), Western Blotting and Immunofluorescence. Mice myocardial ischemia/ reperfusion (I/R) and myocardial infarc- tion (MI) models and doxorubicin induced rat HF model were established to confirm the heart expression of Sesns. Sesn2 was significantly increased, whereas, no alteration for Sesn1 or Sesn3 in failing hearts when comparing with control hearts. Unexpectedly, the mRNA expression of Sesn2 in ischemic cardiomyopathy was higher than that in dilated cardiomyopathy. Immunofluorescence staining revealed all Sesns were expressed in non-cardiomyocytes in human heart. Furthermore, Sesn2 was co-expressed with vimentin, a marker for fibroblasts. Correlation analysis demonstrated Sesn2 levels were significantly correlated with expression levels of natriuretic peptide B (NPPB) and connective tissue growth factor (CTGF), markers for severity of HF and cardiac fibrosis. Meanwhile, the increased Sesn2 was validated in mice I/R and MI models, and also in doxorubicin induced rat HF model. Conclusions: Sesn2, which is expressed in cardiac fibroblasts, could be a potential biomarker to reflect the severity of HF and might play an important role during cardiac remodeling. Keywords: Heart failure, Sestrin, oxidative stress, fibrosis, biomarker Introduction and Sesn3), while most invertebrate express only one Sesn. The Sesn family proteins can be Redox signaling plays important role not only in induced by a variety of environmental stresses, physiological processes, but also in pathologi- including DNA damage, oxidative stress, and cal conditions in heart. At low concentrations, hypoxia [6, 8]. Once induced, Sesns can protect ROS modulate excitation-contraction coupling, cells against oxidative stress [9-11]. cell proliferation and differentiation through changes in cellular signalling and gene expres- It has been revealed that Sesn can maintain sion [1-3]. However, overproduction of ROS may cardiac function against aging in Drosophila result adverse cardiac remodeling, leading to [12]. Sesn null mutants and heart-specific de- further worsening of cardiac function [1]. It is pletion of Sesn cause irregularity of heart- accepted that oxidative stress is at least one beat, cardiac dilation, ultimately leading to de- main cause of heart failure (HF) [4]. Target- creased cardiac function [12]. Recently, a pro- ing oxidative stress is becoming an important tective function of Sesn2 against cardiac isch- strategy to fight HF. emia and reperfusion injury was demonstrated in mice. However, the expression and function Sestrins (Sesns) are highly conserved proteins of Sesns during HF remains unclear. In the pres- originally identified as critical antioxidant with ent study, we aimed to examine the expression sulfinic acid reductase activity, which is neces- of Sesns in human and experimental failing sary for the recycling of peroxiredoxin [5-7]. hearts, and explore their correlation with cardi- Mammals express three Sesns (Sesn1, Sesn2, ac function and fibrosis. Sestrin2 expression in heart failure Table 1. Primer pairs used in the present study thetize mice through intra- Target name Forward primer Reverse primer peritoneal injections (50 mg/ kg, Sigma-Aldrich). To estab- H-GAPDH GGATTTGGTCGTATTGGGCG TTCCCGTTCTCAGCCTTGAC lish myocardial ischemia/re- H-NPPB TCAGCCTCGGACTTGGAAAC AGACCCTTGCACCATCTTGG perfusion (I/R) model, a medi- H-CTGF CGACTGGAAGACACGTTTGG TGCAGGAGGCGTTGTCATT an sternotomy was perform- H-Sesn1 GCATGTTCCAACATTTCGTG TCCCACATCTGGATAAAGGC ed. And then the left coronary H-Sesn2 GCAGGGCCATCTGGAACTAT GTGCCTCCAGAAGAGGTTGT artery (LCA) was ligated with H-Sesn3 ATGCTTTGGCAAGCTTTGTT GCAAGATCACAAACGCAGAA a piece of tubing placed be- R-GAPDH ACGGGAAACCCATCACCATC TGGTGGTGCAGGATGCATTG tween the LCA and the su- R-NPPB TTCCTTAATCTGTCGCCGCTGG CAGCAGCTTCTGCATCGTGGAT ture to minimize coronary ar- tery trauma induced by occlu- R-Sesn1 ACCGAGTACCTTCGTTCTGC ACAGCATAAGCAGATGGGCA sion and to facilitate reperfu- R-Sesn2 CCTTTGTGTTTGGCTGTGGG AGAGCTTCTATGTCACGGGC sion. Reperfusion was initiat- R-Sesn3 CAATGGCCACCCATGAGGAT GCTGTCATACATGCGCTTCG ed after 1 h of occlusion. The M-GAPDH TGATGGGTGTGAACCACGAG TCATGAGCCCTTCCACGATG thoracic cavity was closed, M-NPPB GAGGTCACTCCTATCCTCTGG GCCATTTCCTCCGACTTTTCTC and the animal was extuba- M-Sesn1 GGACGAGGAACTTGGAATCA ATGCATCTGTGCGTCTTCAC ted after recovering consci- M-Sesn2 TAGCCTGCAGCCTCACCTAT TATCTGATGCCAAAGACGCA ousness. The hearts were M-Sesn3 TTACTTGAACGGAGCCTGAAG TCCATCAGAAGCAGATTCACG harvested after reperfusion with 24 h. Same procedure was repeated to establish Materials and methods myocardial infarction (MI) model, and the tho- racic cavity was closed after occlusion of the Human heart tissues LCA. The hearts were harvested at 1 week and 4 weeks after operation. Sham-operated Human heart tissues were collected from animals underwent the same surgical proce- transplanted hearts with end-stage heart fail- dure without LCA occlusion. ure, without diabetes mellitus. All samples were obtained from identical myocardial loci Doxorubicin induced rat heart failure model of left-ventricular to extremely ensure optimal uniformity. Control hearts were procured from Male SD (6-8 weeks old) rats were purchased organ donators who died of traffic accidents from Hunan SJA Laboratory Animal Co., Ltd. with no cardiac disease history. These hearts and were randomly divided into two groups. had originally been intended for transplan- The doxorubicin (Dox) group received Dox (2.5 tation, but failed to get suitable matching re- mg/kg/week) through intraperitoneal inject- cipients. The hearts were immediately dissec- ion for 6 weeks. The control group received tion into small portions, snap-frozen in liquid same volume saline as the same way. Two nitrogen, and then maintained at -80°C until weeks after the last injection, the rats were using. Heart samples used for pathological sacrificed and heart samples were collected study were fixed in 10% phosphate-buffered for research. formalin and embedded in paraffin. Quantitative real-time polymerase chain reac- Fully informed consent was obtained from all tion patients or family members before partici- pating in the study. This study protocol was Total RNA was extracted from heart tissue approved by the Ethics Committee of Renmin with TRIzol reagent (Roche, Indiana) as the Hospital of Wuhan University. manual instructed, and the concentration was assessed by Nanodrop 2000. A total of Mice myocardial ischemia/reperfusion and 2 μg RNA was used to synthesis cDNA using myocardial infarction models Transcriptor First Stand cDNA Synthesis Kit (Roche). Quantitative real-time PCR (qRT-PCR) Male C57BL/6 (8-10 weeks old) mice were pur- was performed with the LightCycler 480 SYBR chased from Hunan SJA Laboratory Animal Co., Green I Master (Roche) using the LightCycler Ltd. Pentobarbital sodium was used to anes- 480 real-time PCR system according to the 8076 Int J Clin Exp Pathol 2016;9(8):8075-8082 Sestrin2 expression in heart failure Table 2. Characteristics for heart failure patients staining was performed to Heart failure (n=28) detect collagen deposition. CTL (n=10) ICM (n=10) DCM (n=18) Immunofluorescence staining was used to further confirm Gender male, n 10 8 15 the expression and the loca- Age (yr), mean ± SD 52.30 ± 4.42 54.00 ± 5.42# 52.93 ± 7.40# tion of Sesns in heart. After LVEDD (mm), mean ± SD - 65.60 ± 10.37 69.63 ± 9.72* a 5-min high-pressure anti- LVEF (%), mean ± SD - 29.80 ± 5.09 25.58 ± 9.20* gen retrieval process (sodium CTL: Control hearts; ICM: Ischemic cardiomyopathy; DCM: Dilated cardiomyopathy; citrate buffer, 100×, pH 6.0), LVEDD: Left ventricular end diastolic diameter; LVEF: Left ventricular ejection frac- tion. #P>0.05 vs. CTL; *P>0.05 vs. ICM. the heart sections were incu- bated in PBS containing 10% fetal bovine serum for 60 min manufacturer’s instructions (Roche). The prim- and subsequently incubated overnight at 4°C er pairs were designed online using Primer- with the primary antibodies. The sections were Blast and were shown in Table 1. The PCR con- then washed with PBS and incubated with ditions used were as follows: initial denatur- the appropriate secondary antibodies for 1 h ation at 95°C for 10 minutes, followed by 40 at 37°C. The secondary antibodies used were cycles of 95°C for 10 seconds (denaturation), goat anti-rabbit IgG Alexa Fluor 568 conju- 60°C for 10 seconds (annealing), and 72°C for gate (Invitrogen, CA) and anti-mouse IgG Alexa 20 seconds (extension). The relative expres- Fluor 568 conjugate (Invitrogen, CA). The nu- sion levels of mRNAs were normalized to